Issue |
Title |
File |
Vol 14, No 4 (2017) |
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V |
(Rus)
|
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Panchenko E.P., Fedotkina Y.A., Stenina M.B., Trophimova O.P., Ageev F.T.
|
Vol 15, No 1 (2018) |
Clinical manual for diagnosis, prevention and treatment of cardiovascular complications of cancer therapy. Parts VI-VII |
(Rus)
|
Chazova I.Y., Tyulyandin S.A., Vitsenia M.V., Panchenko E.P., Fedotkina Y.A., Poltavskaya M.G., Gilyarov M.Y., Martynyuk T.V., Ovchinnikov A.G., Stenina M.B., Trophimova O.P., Ageev F.T.
|
Vol 17, No 3 (2020) |
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease |
(Rus)
|
Chazova I.E., Nevzorova V.A., Ambatiello L.G., Brodskaia T.A., Oshchepkova E.V., Belevskii A.S., Zhernakova J.V., Aisanov Z.R., Ovcharenko S.I., Chuchalin A.G.
|
Vol 14, No 2 (2017) |
Clinical-pharmacological priorities in the election of blockators of the renin-angiotenzine system and diuretics in patients with uncompleted hypertension |
(Rus)
|
Ponomareva A.I., Ketova G.G., Kompaniets O.G.
|
Vol 10, No 4 (2013) |
Clinico-pharmacological aspects of metoprolol use |
|
Anikin G.S., Chernova I.M., Vinokurov V.G.
|
Vol 13, No 4 (2016) |
Coagulation markers in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressure |
(Rus)
|
Bugaev T.D., Elfimova E.M., Ageeva N.V., Dobrovolskiy A.B., Litvin A.Y.
|
Vol 10, No 4 (2013) |
Coagulogic risk factors of heart disease in the adult population of Tomsk |
|
Dobrovolsky A.B., Titaeva E.V., Yarovaya E.B., Storozhilova A.N., Zhernakova Y.V., Oschepkova E.V., Panchenko E.P., Trubacheva I.A., Serebryakova V.N., Kaveshnikova V.S., Chazova I.E., Karpov R.S.
|
Vol 18, No 1 (2021) |
Combined antihypertensive and psychocorrective therapy in patients with arterial hypertension and anxiety-depressive disorders: are there any advantages? |
(Rus)
|
Skibitsky V.V., Ginter J.E., Fendrikova A.V., Sirotenko D.V.
|
Vol 15, No 4 (2018) |
Combined antihypertensive therapy in the light of modern recommendations: strategy of one tablet |
(Rus)
|
Morozova T.E.
|
Vol 6, No 2 (2009) |
Combined low-dose therapy of arterial hypertension |
|
Stryuk R.I.
|
Vol 10, No 2 (2013) |
Combined pharmacotherapy for arterial hypertension: a view through the 2013 clinical practice guidelines |
|
Rodionov A.V.
|
Vol 13, No 3 (2016) |
Combined pharmacotherapy of arterial hypertension. Overview fixed combination antihypertensive drugs |
(Rus)
|
Morozova T.E., Andrushchishina T.B., Yudina I.Y.
|
Vol 15, No 4 (2018) |
Communication of subcutaneous, visceral, periaortic, epicardial fat and metabolic parameters with arterial stiffness in young people with abdominal obesity |
(Rus)
|
Zheleznova E.A., Zhernakova Y.V., Chazova I.E., Rogoza A.N., Zairova A.R., Shariya M.A., Yarovaya E.B., Orlovsky A.A., Blinova N.V., Azimova M.O., Gorieva S.B., Konosova I.D.
|
Vol 18, No 2 (2021) |
Comparative characteristics of indicators of peripheral arterial and central aortic pressure, remodeling of the left ventricular myocardium in salt-sensitive and salt-resistant patients with arterial hypertension |
(Rus)
|
Skibitskiy V.V., Vasil'ev V.Y., Fendrikova A.V., Pyatakov S.N.
|
Vol 10, No 1 (2013) |
Comparative characterizations of patients with hypertensive disease in the mid-1980s and in the 2010s (the patients’ portraits in the context of factor analysis) |
|
Zakharova E.G., Fursov A.N., Potekhin N.P.
|
Vol 11, No 3 (2014) |
Comparative evaluation of zofenopril. Are the characteristics of angiotensin I converting enzyme inhibitors important for the practice? |
(Rus)
|
Kirichenko A.A.
|
Vol 16, No 2 (2019) |
Comparison of effectiveness of therapy with lisinopril and fosinopril in patients with diastolic chronic heart failure in the presence of hypertension disease |
(Rus)
|
Merzlyakova S.N., Shubitidze I.Z., Tregubov V.G., Pokrovskiy V.M.
|
Vol 12, No 2 (2015) |
Comparison of the effectiveness of preparations containing moxonidine during emergency antihypertensive therapy |
(Rus)
|
Ruksin V.V., Grishin O.V., Onuchin M.V.
|
Vol 12, No 4 (2015) |
Comparison of vectorcardiographic parameters with structural-functional state of the right ventricle in patients with pulmonary hypertension |
(Rus)
|
Blinova E.V., Sakhnova T.A., Saidova M.A., Loskutova A.S., Ryabykina G.V., Arkhipova O.A., Martynyuk T.V., Trunov V.G., Aidu E.A., Chazova I.E.
|
Vol 14, No 1 (2017) |
Comprehensive assessment of cardiovascular risk factors of arterial hypertension in indigenous and non-indigenous inhabitants of Mountain Shoria |
(Rus)
|
Mulerova T.A., Maksimov S.A., Ogarkov M.Y.
|
Vol 18, No 2 (2021) |
Consensus of experts from the Russian Medical Society of Arterial Hypertension. Arterial hypertension and erectile dysfunction |
(Rus)
|
Alekseeva T.A., Litvin A.Y., Elfimova E.M., Mikhailova O.O., Larina V.N., Shpot E.V., Podzolkov V.I., Chazova I.E.
|
Vol 16, No 4 (2019) |
Consensus on patients with hyperuricemia and high cardiovascular risk treatment |
(Rus)
|
Chazova I.E., Zhernakova J.V., Kisliak O.A., Nedogoda S.V., Podzolkov V.I., Oshchepkova E.V., Medvedeva I.V., Mironova O.I., Blinova N.V.
|
Vol 15, No 2 (2018) |
Continuous positive airway pressure (CPAP) therapy in patients with obstructive sleep apnea syndrome and arterial hypertension: expert opinion |
(Rus)
|
Litvin A.Y., Elfimova E.M., Chazova I.E.
|
Vol 6, No 3 (2009) |
Contraindications and adverse events of drugs in cardioneurological patients. |
|
Kompaniets O.G.
|
Vol 17, No 4 (2020) |
Contrast-associated acute kidney injury in patients with arterial hypertension and coronary artery disease and its long-term prognosis |
(Rus)
|
Mironova O.I., Fomin V.V.
|
Vol 17, No 3 (2020) |
Contrast-associated acute kidney injury in patients with arterial hypertension and stable coronary artery disease |
(Rus)
|
Mironova O.I., Fomin V.V.
|
Vol 13, No 3 (2016) |
Control of cardiovascular risk in patients with diabetes |
(Rus)
|
Zhernakova Y.V., Chazova I.E.
|
Vol 17, No 2 (2020) |
COVID-19: a patient with cardiovascular disease at high risk |
(Rus)
|
Chazova I.E., Zhernakova Y.V., Ostroumova O.D.
|
Vol 10, No 3 (2013) |
Covremennye predstavleniya ob ideal'noy kombinatsii antigipertenzivnykh preparatov dlya profilaktiki insul'ta |
|
Ostroumova O.D., Fomina V.M., Guseva T.F.
|
Vol 13, No 1 (2016) |
Current possibilities of nuclear imaging in arterial hypertension |
(Rus)
|
Ansheles A.A., Sergienko V.B.
|
Vol 13, No 2 (2016) |
Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis |
(Rus)
|
Yudkina N.N., Valeeva E.G., Taran I.N., Nikolaeva E.V., Paramonov V.M., Kurmukov I.A., Valieva Z.S., Arkhipova O.A., Martynyuk T.V., Volkov A.V., Nasonov E.L., Chazova I.E.
|
Vol 12, No 3 (2015) |
Dependence of the efficiency of the initial state of fosinopril structure common carotid arteries, intravascular blood flow and central hemodynamics at patients with arterial hypertension |
(Rus)
|
Melnikova L.V., Bartosh L.F., Grechishkina O.A.
|
Vol 16, No 1 (2019) |
Diagnosis and treatment of arterial hypertension [Guidelines] |
(Rus)
|
Chazova I.E., Zhernakova Y.V.
|
Vol 7, No 3 (2010) |
Diagnostika i lechenie arterial'noy gipertenzii(Rekomendatsii Rossiyskogo meditsinskogo obshchestva po arterial'noy gipertonii i Vserossiyskogo nauchnogo obshchestva kardiologov) |
|
Chazova I.E., Ratova L.G., Boytsov S.A., Nebieridze D.V.
|
Vol 7, No 4 (2010) |
Diagnostika postprandial'noy gipotenzii u bol'nykh s sindromom kompressii chrevnogo stvola. |
|
Tyurina T.V., Ignashov A.M., Vrabiy A.A., Maslevtsov D.V.
|
Vol 14, No 1 (2017) |
Dihydropyridine calcium antagonists: conscious choice |
(Rus)
|
Ostroumova O.D., Vikentev V.V., Abrosimov A.G., Smoliarchuk E.A.
|
Vol 8, No 3 (2011) |
Dinamika ekhokardiograficheskikhparametrov u patsientovs arterial'noy gipertonieyi gipertrofiey levogo zheludochkav protsesse terapii perindoprilaargininom (Prestariumom A) |
|
Dudarev M.V., Odintsova N.F., Vasil'ev M.Y., Nikolaeva A.V., Mel'nikov A.V.
|
Vol 9, No 2 (2012) |
Dinamika obratnogo remodelirovaniya serdtsa i sosudov u bol'nykh gipertonicheskoy bolezn'yu v zavisimosti ot vybora i taktiki naznacheniya antigipertenzivnoy terapii so starta |
|
Kovalevskaya N.A., Koziolova N.A., Bushmakina A.V., Shatunova I.M.
|
Vol 5, No 3 (2008) |
Dinamika skorosti klubochkovoy fil'tratsii - samostoyatel'naya mishen' antigipertenzivnoy terapii: vozmozhnosti eprosartana |
|
Fomin V.V.
|
Vol 8, No 4 (2011) |
Dinamika urovnya arterial'nogo davleniya po dannym klinicheskogo izmereniya i sutochnogo monitorirovaniya u bol'nykh starshe 75 let na fone monoterapii indapamidom retard |
|
Kobalava Z.D., Markova M.A.
|
Vol 6, No 4 (2009) |
Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome |
|
Chazova I.E., Fomin V.V.
|
Vol 11, No 4 (2014) |
Dispersible Prestarium A tablets in the treatment of patients with arterial hypertension |
(Rus)
|
Malchikova S.V., Tarlovskaya Y.I.
|
Vol 9, No 4 (2012) |
Diuretics in arterial hypertension: a focus on torasemide |
|
Baryshnikova G.A., Stepanova I.I.
|
Vol 13, No 2 (2016) |
Diuretics in combination antihypertensive therapy: focus on forecast |
(Rus)
|
Chazova I.E., Martyniuk T.V.
|
Vol 6, No 4 (2009) |
Diuretics in treatment of patients with arterial hypertension |
|
Chazova I.E., Ratova L.G.
|
Vol 4, No 1 (2007) |
Diuretiki pri arterial'noy gipertenzii: vse li problemy resheny? |
|
Nedogoda S.V.
|
Vol 9, No 4 (2012) |
Diurnal blood pressure variability as a risk factor for complications of arterial hypertension |
|
Ostroumova O.D., Reznikova K.U.
|
Vol 10, No 2 (2013) |
Do spirometry for patients with cardiovascular diseases? |
|
Nazarov B.M., Zykov K.A., Ratova L.G., Agapova O.Y., Dolgusheva Y.A., Chazova I.E.
|
Vol 17, No 2 (2020) |
DOACs: life-changing technologies |
(Rus)
|
Panchenko E.P., Shakhnovich R.M., Ageev F.T., Komarov A.L.
|
Vol 5, No 2 (2008) |
Dokazatel'naya baza primeneniya amlodipina pri lechenii arterial'noy gipertenzii |
|
Nedogoda S.V., Brel' U.A.
|
Vol 8, No 2 (2011) |
Dokazatel'nyy analiz rezul'tatovsutochnogo monitorirovaniyaarterial'nogo davleniya u deteyi podrostkov |
|
Delyagin V.M., Novikova T.A., Olimpieva S.P., Kilikovskiy V.V., Sinyakovich N.B., Dubovik L.G., Kolbatova E.S., Levano U.L., Urazbagambetov A.
|
Vol 9, No 1 (2012) |
Dostizhenie tselevykh urovney arterial'nogo davleniya na fone priema fiksirovannoy kombinatsii perindoprila 10 mg i indapamida 2,5 mg u patsientov s nekontroliruemoy arterial'noy gipertenziey 2-3-y stepeni |
|
Chazova I.E., Litvin A.Y., Aksenova A.V., Elfimova E.M., Galitsin P.V.
|
Vol 18, No 2 (2021) |
Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project |
(Rus)
|
Bontsevich R.A., Vovk Y.R., Gavrilova A.A., Kirichenko A.A., Krotkova I.F., Kosmacheva E.D., Kompaniets O.G., Prozorova G.G., Nevzorova V.A., Martynenko I.M., Ketova G.G., Barysheva V.O., Maksimov M.L., Osipova O.A.
|
Vol 16, No 2 (2019) |
Drug-induced arterial hypertension |
(Rus)
|
Ostroumova O.D., Kulikova M.I.
|
Vol 11, No 4 (2014) |
Dynamics of arterial hypertension and its impact on mortality in the Russian population |
(Rus)
|
Balanova Y.A., Shalnova S.A., Deyev A.D., Konstantinov V.V., Kapustina A.V.
|
Vol 6, No 3 (2009) |
Dynamics of blood pressure, heart rate variability and QTc in patients with metabolic syndrome on the selective betablockerand biguanide therapy. |
|
Ryabykina G.V., Shishova T.A., Laptev D.N., Mychka V.B., Lyutikova L.N., Kozhemyakina E.S., Shchedrina E.V., Sobolev A.V., Chazova I.E.
|
Vol 14, No 3 (2017) |
Dynamics of clinico-psychological characteristics in patients with obstructive sleep apnea syndrome and arterial hypertension after one month of the use of CPAP therapy |
(Rus)
|
Konovalova K.I., Elfimova E.M., Mikhailova O.O., Fedorova V.I., Litvin A.Y.
|
Vol 16, No 2 (2019) |
Dynamics of ECG indicators in patients with chronic thromboembolic pulmonary hypertension after transluminal pulmonary balloon angioplasty |
(Rus)
|
Karabasheva M.B., Danilov N.M., Sagaidak O.V., Matchin I.G., Chazova I.E.
|
Vol 11, No 3 (2014) |
Education and self-education of the patients is an important step towards increasing patients acceptance of therapy |
(Rus)
|
Chazova I.Y., Ageev F.T., Fofanova T.V., Chikhladze N.M., Kuznetsova M.B., Smirnova M.D., Ostrogorskaya V.A., Geraschenko Y.S.
|
Vol 10, No 1 (2013) |
Effect of adrenalectomy on the condition of the myocardium and arteries in hypertensive patient with primary hyperaldosteronism |
|
Valieva Z.S., Chikhladze N.M., Sakhnova T.A., Blinova E.V., Panteleev I.V., Tripoten M.I., Balakhonova T.V., Chazova I.E.
|
Vol 10, No 2 (2013) |
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome |
|
Nedogoda S.V., Salasyuk A.S., Chalyabi T.A., Barykina I.N., Pocheptsov D.A., Ledyaeva A.A., Tsoma V.V., Chumachek E.V.
|
Vol 13, No 4 (2016) |
Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension |
(Rus)
|
Shchelkova G.V., Zairova A.R., Danilov N.M., Rogoza A.N., Chazova I.E.
|
Vol 11, No 3 (2014) |
Effect of sildenafil on clinical evidence and hemodynamic parameters in patients with pulmonary arterial hypertension, associated withsystemic rheumaticdiseases |
(Rus)
|
Volkov A.V., Udkina N.N., Kurmukov I.A., Nikolaeva Y.A., Nasonov Y.L.
|
Vol 10, No 1 (2013) |
Effect of the fixed-dose combination Ekvator on blood pressure level and cognitive functions in elderly patients with arterial hypertension |
|
Ostroumova O.D., Pervichko E.I.
|
Vol 12, No 2 (2015) |
Effectiveness and safety of indapamide sustained-release in the treatment of post partial hypertension |
(Rus)
|
Gaisin I.R., Iskchakova A.S., Shilina L.V., Maksimov N.I., Vavilkina Z.V., Sava N.P.
|
Vol 12, No 4 (2015) |
Effectiveness of combined antihypertensive treatment depending on the phenomenon of salt sensitivity in patients with refractory arterial hypertension |
(Rus)
|
Skibitskiy V.V., Garkusha E.S., Fendrikova A.V.
|
Vol 12, No 1 (2015) |
Effects of amlodipine and atorvastatin on endothelial vasoactive mediators in patients with metabolic syndrome |
(Rus)
|
Blinova N.V., Masenko V.P., Chazova I.E.
|
Vol 11, No 2 (2014) |
Effects of loop diureticswith differenthalf-elimination times on natriuresis changes in hypertensive patients with different blood pressure profile |
(Rus)
|
Arutyunov G.P., Dragunov D.O., Sokolova A.V.
|
Vol 18, No 1 (2021) |
Effects of the b-blockers on the functional state of patients with ventricular arrhythmias |
(Rus)
|
Shubitidze I.Z., Tregubov V.G.
|
Vol 7, No 3 (2010) |
Effektivnaya antigipertenzivnaya terapiya u bol'nykh s metabolicheskim sindromom |
|
Mychka V.B., Blinova N.V., Chazova I.E.
|
Vol 3, No 2 (2006) |
Effektivnoe i bezopasnoe ispol'zovanie perindoprila v doze 8 mg v kachestve startovogo lecheniya bol'nykh arterial'noy gipertoniey v usloviyakh statsionara (po rezul'tatam issledovaniya DOMINANTA) |
|
Ostroumova O.D., Barabash O.L., Bondareva Z.G., Yakhontov D.A., Pereskal'skaya M.A., Mordvinova N.I., Paukov S.V.
|
Vol 7, No 2 (2010) |
Effektivnost' i bezopasnost' kombinatsii amlodipina i valsartana v lechenii arterial'noy gipertonii v usloviyakh real'noy klinicheskoy praktiki: pervye rezul'taty rossiyskogo nablyudatel'nogo issledovaniya EKSTRA |
|
Chazova I.E., Karpov Y.A., Vigdorchik A.V.
|
Vol 2, No 1 (2005) |
Effektivnost' i bezopasnost' primeneniya Betaloka ZOK i Logimaksa u bol'nykh myagkoy arterial'noy gipertenziey v sochetanii s khronicheskoy obstruktivnoy bolezn'yu legkikh |
|
Chazova I.E., Litvin A.Y., Galitsin P.V., Ageeva N.V., Ratova L.G.
|
Vol 2, No 1 (2005) |
Effektivnost' i bezopasnost' sovremennykh mochegonnykh preparatov u patsientov s arterial'noy gipertoniey oslozhnennogo techeniya |
|
Chazova I.E.
|
Vol 3, No 2 (2006) |
Effektivnost' i bezopasnost' tsilazaprila u patsientov s arterial'noy gipertoniey, perenesshikh insul't i/ili tranzitornuyu ishemicheskuyu ataku |
|
Chazova I.E., Kolos I.P., Fedorova V.I., Pustovitova T.S., Ustyuzhanin D.V., Sinitsyn V.E., Starchina Y.A.
|
Vol 5, No 1 (2008) |
Effektivnost' i perenosimost' fozinoprila u bol'nykh arterial'noy gipertoniey |
|
Morozova T.E., Andrushchishina T.B.
|
Vol 5, No 2 (2008) |
Effektivnost' i perenosimost' preparata Tarka u bol'nykh arterial'noy gipertenziey (programma TANDEM) |
|
Chazova I.E., Ratova L.G.
|
Vol 8, No 1 (2011) |
Effektivnost' kompleksnoy medikamentoznoy i CPAP-terapii u patsientov s arterial'noy gipertoniey 2-3-y stepeni i tyazheloy stepen'yusindroma obstruktivnogo apnoe vo vremya sna. |
|
Sukmarova Z.N., Litvin A.Y., Chazova I.E., Rogoza A.N.
|
Vol 4, No 1 (2007) |
Effektivnost' lecheniya gipertonicheskoy bolezni perindoprilom molodykh muzhchin |
|
Bubnova V.S., Lebedev E.V., Shaposhnik I.I.
|
Vol 8, No 4 (2011) |
Effektivnost' lozartana u bol'nykh arterial'noy gipertoniey s gipertrofiey miokarda levogo zheludochka |
|
Chikhladze N.M., Sakhnova T.A., Blinova E.V., Yarovaya E.B., Chazova I.E.
|
Vol 5, No 4 (2008) |
Effektivnost' primeneniya kandesartana pri gipertonicheskoy boleznii nefrogennoy arterial'noy gipertonii |
|
Chikhladze N.M., Sivakova O.A., Blinova E.V., Sakhnova T.A., Kolos I.P., Litonova G.N., Chazova I.E.
|
Vol 9, No 3 (2012) |
Effektivnost' terapii lerkanidipinom pri arterial'noy gipertenzii u pozhilykh |
|
Chikhladze N.M.
|
Vol 1, No 2 (2004) |
Effektivnost' vozdeystviya blokatora AT1-angiotenzinovykh retseptorov irbesartana na organy-misheni u bol'nykh arterial'noy gipertoniey |
|
Chikhladze N.M., Chazova I.E.
|
Vol 11, No 2 (2014) |
Efficacy and safety of amlodipine and perindopril (Prestance) fixed combination in patients with arterial hypertension during the summer heat |
(Rus)
|
Chazova I.E., Ageev F.T., Smirnova M.D., Ageeva N.V., Fofanova T.V., Svirida O.N., Mikhailov G.V., Levin A.M., Revich B.A.
|
Vol 18, No 3 (2021) |
Efficacy and safety of azilsartan medoxomil in various doses in patients with metabolic disorders |
(Rus)
|
Perepech N.B., Chazova I.E., Zhernakova J.V.
|
Vol 12, No 2 (2015) |
Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension |
(Rus)
|
Elfimova E.M., Aksenova A.V., Litvin A.Y., Chazova I.E.
|
Vol 11, No 2 (2014) |
Efficacy and safety of Mertenil (rosuvastatin) 40 mg in patients with familial hypercholesterolemia |
(Rus)
|
Zubareva M.Y., Malyshev P.P., Rozhkova T.A., Kuharchuk V.V.
|
Vol 17, No 4 (2020) |
Efficacy and safety of using a fixed-dose combination of azilsartan medoxomil and chlorthalidone in patients with diabetes mellitus |
(Rus)
|
Zhernakova J.V., Chazova I.E.
|
Vol 6, No 3 (2009) |
Efficacy of amlodipin in treatment of arterial hypertension. |
|
Prokhorovich E.A.
|
Vol 10, No 2 (2013) |
Efficacy of irbesartan in arterial hypertension and metabolic syndrome |
|
Ostroumova O.D., Zykova A.A., Polosova T.A., Bondarets O.V.
|
Vol 6, No 2 (2009) |
Efficacy of metoprolol in treatment and preventive of cardiovascular diseases |
|
Chazova I.E., Ratova L.G., Ratova L.G., Chazova I.E.
|
Vol 6, No 3 (2009) |
Efficacy of the fixed combination β-blocker and calcium antagonist Logimax at women with an essential hypertensionin different age groups |
|
Ostroumova O.D., Zhukova O.V., Golovina O.V., Srednyakov A.V., Otdelenov A.V.
|
Vol 9, No 4 (2012) |
Electrical and viscoelastic parameters of erythrocytes in patients with different degrees of arterial hypertension |
|
Gromov A.A., Kruchinina M.V., Rabko A.V., Baum V.A., Generalov V.M.
|
Vol 15, No 2 (2018) |
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment |
(Rus)
|
Arkhipova O.A., Martynyuk T.V.
|
Vol 6, No 1 (2009) |
Endothelium dysfunction at arterial hypertension: focus on nebivolol |
|
Vaulin N.A.
|
Vol 5, No 2 (2008) |
Endovaskulyarnye metody issledovaniya i lecheniya v kardiologii: vremya yubileev i somneniy |
|
Gorgadze T.T., Danilov N.M., Savchenko A.P., Chazova I.E.
|
Vol 15, No 4 (2018) |
Epicardial fat: a new cardiometabolic risk marker, a new therapeutic goal in obese patients |
(Rus)
|
Blinova N.V., Zhernakova Y.V., Azimova M.O., Azimova M.R., Chazova I.E.
|
Vol 7, No 3 (2010) |
Epidemiologicheskaya kharakteristika rezistentnoy i nekontroliruemoy arterial'noy gipertenzii v Rossiyskoy Federatsii(Rossiyskiy registr nekontroliruemoy i rezistentnoy arterial'noy gipertenzii REGATA-PRIMA «REzistentnaya Gipertoniya ArTeriAl'naya - PRichiny I Mekhanizmy rAzvitiya») |
|
Chazova I.E., Fomin V.V., Razuvaeva M.A., Vigdorchik A.V.
|
Vol 2, No 1 (2005) |
Epidemiologiya insul'ta v Rossiyskoy Federatsii |
|
Skvortsova V.I., Stakhovskaya L.V., Ayriyan N.Y.
|
Vol 13, No 3 (2016) |
Ethnogenetic aspects of obesity and disorders of carbohydrate metabolism as a risk factor of arterial hypertension |
(Rus)
|
Mulerova T.A., Tsygankova D.P., Voropaeva E.N., Maksimov V.N., Ogarkov M.Y.
|
101 - 200 of 734 Items |
<< < 1 2 3 4 5 6 7 8 > >> |